Status:
COMPLETED
System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts
Lead Sponsor:
University of Massachusetts, Worcester
Collaborating Sponsors:
Reliant Medical Group
Pfizer
Conditions:
Influenza
Infections, Pneumococcal
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this research study is to improve rates of appropriate influenza and pneumococcal vaccination among adults who receive care at a large multi-specialty group practice in central Massachuset...
Detailed Description
The study's multifaceted approach will address the gap between current and optimal vaccination rates via patient-, provider- and system-level interventions intended to target local barriers. Patient-...
Eligibility Criteria
Inclusion
- RMG Patients 18 years of age or older.
- Overdue for vaccination against influenza and/or not up to date on vaccination for pneumococcal vaccine per RMG EHR data
- No documented allergy to the vaccination in question.
Exclusion
- Failure to meet inclusion criteria.
- Patients who have selected the "Do not call" option in the RMG EHR or have an allergy to the influenza and/or pneumococcal vaccination will be excluded from participation.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT02266277
Start Date
November 1 2014
End Date
December 1 2016
Last Update
May 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reliant Medical Group
Worcester, Massachusetts, United States, 01605